News

13.04.2026, 17:05

Extended Phase II study with Arnica against CL started in Colombia!

The extended clinical study investigating the efficacy of Arnica tincture against cutaneous Leishmaniasis has officially started at the University of Antioquia, Colombia: The first of 70 envisaged patients has...   mehr

31.03.2026, 17:16

ResNet NPND welcomes new member from France

The network cordially welcomes Dr. Sébastien Pomel of the äuniversité Paris-Saclay, Orsay, France, as a new member. Dr. Pomel has great expertise in antiparasitic bioactivity testing and parasite biochemistry...   mehr

19.09.2025, 14:23

Successful Clinical Study: Arnica does WORK against CL !

The ResNet NPND groups of Sara M. Robledo (Colombia) and T. J. Schmidt (Germany) have recently published the very successful outcome of their first clinical study with Colombian Cutaneous Leishmaniasis (CL)...   mehr

26.03.2025, 13:54

ResNet NPND welcomes a new member from Korea

ResNet NPND cordially welcomes as new member Professor Hyung Min Kim from the College of Pharmacy, Chungnam National University, Daejeon, Korea. We are glad to include him in the network as a representative of...   mehr

18.02.2025, 09:26

ResNet NPND welcomes a new member from Cameroon

The network cordially welcomes Dr. Théodora Kopa-Kowa from the Institute of Medical Research and Medicinal Plants Studies (IMPM), Ministry of Scientific Research and Innovation (MINRESI), Cameroon. We are...   mehr